Neurocysticercosis
ICD-10 B69.0 is a billable code used to indicate a diagnosis of neurocysticercosis.
Neurocysticercosis is a parasitic infection caused by the larval stage of the Taenia solium tapeworm, commonly known as the pork tapeworm. This condition occurs when the larvae invade the central nervous system, leading to a range of neurological symptoms. The infection is prevalent in regions where pigs are raised and where sanitation practices are inadequate. Patients may present with seizures, headaches, and other neurological deficits, depending on the location and number of cysts in the brain. Diagnosis is typically confirmed through imaging studies such as MRI or CT scans, which reveal cystic lesions. Treatment often involves antiparasitic medications such as albendazole or praziquantel, along with corticosteroids to manage inflammation. Neurocysticercosis can lead to significant morbidity, and in severe cases, it may be life-threatening if not treated promptly.
Detailed neurological examination findings, imaging results, and treatment plans.
Patients presenting with seizures, headaches, or cognitive changes.
Ensure thorough documentation of neurological deficits and imaging studies to support the diagnosis.
History of exposure, travel history, and treatment response.
Patients with a history of travel to endemic areas presenting with neurological symptoms.
Document any co-infections or other parasitic diseases that may complicate the case.
Used when administering antiparasitic treatment in an inpatient setting.
Document the reason for infusion and the medication administered.
Ensure that the infusion is linked to the diagnosis of neurocysticercosis.
Common symptoms include seizures, headaches, confusion, and other neurological deficits, depending on the location of the cysts in the brain.
Diagnosis is typically made through imaging studies such as MRI or CT scans, which reveal cystic lesions in the brain.
Treatment often involves antiparasitic medications like albendazole or praziquantel, along with corticosteroids to reduce inflammation.
